Lv61
2310 积分 2023-03-12 加入
MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies
3天前
已完结
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
13天前
已完结
Design and Discovery of Pyridazinone-Based MAT2A Inhibitors Targeting MTAP-Deficient Cancers
13天前
已完结
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
20天前
已完结
Molecular glue meets antibody: next-generation antibody–drug conjugates
27天前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
1个月前
已完结
The story of amylin: from physiology to therapy
1个月前
已完结
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
2个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
2个月前
已完结
Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions
2个月前
已完结
皖公网安备34019202002308
